| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 2.75e-05 | 579 | 57 | 9 | GO:0045785 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 4.49e-05 | 4 | 57 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 4.84e-05 | 144 | 57 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 8.46e-05 | 162 | 57 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 9.09e-05 | 266 | 57 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 9.38e-05 | 32 | 57 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 1.12e-04 | 6 | 57 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 1.46e-04 | 290 | 57 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB4 ARID1B COL16A1 ARID2 RIPK2 TRIOBP LAMB2 NFKBIZ IL2RG NOTCH4 | 2.02e-04 | 927 | 57 | 10 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 2.36e-04 | 317 | 57 | 6 | GO:1903039 | |
| GeneOntologyBiologicalProcess | positive regulation of CD4-positive, alpha-beta T cell differentiation | 2.61e-04 | 45 | 57 | 3 | GO:0043372 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 2.67e-04 | 9 | 57 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 3.29e-04 | 119 | 57 | 4 | GO:0043367 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 3.69e-04 | 486 | 57 | 7 | GO:0007159 | |
| GeneOntologyBiologicalProcess | response to pain | 3.79e-04 | 51 | 57 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 3.98e-04 | 226 | 57 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation | 4.06e-04 | 227 | 57 | 5 | GO:0046631 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 5.04e-04 | 238 | 57 | 5 | GO:0050954 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 5.27e-04 | 57 | 57 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 5.30e-04 | 135 | 57 | 4 | GO:0009791 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 5.43e-04 | 242 | 57 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 5.43e-04 | 242 | 57 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of CD4-positive, alpha-beta T cell activation | 5.54e-04 | 58 | 57 | 3 | GO:2000516 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 5.74e-04 | 13 | 57 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 6.35e-04 | 382 | 57 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | T cell activation | 6.49e-04 | 701 | 57 | 8 | GO:0042110 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 6.61e-04 | 385 | 57 | 6 | GO:0051251 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 6.68e-04 | 537 | 57 | 7 | GO:0030098 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 6.74e-04 | 62 | 57 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 6.90e-04 | 540 | 57 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 6.98e-04 | 389 | 57 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | behavior | 7.01e-04 | 891 | 57 | 9 | GO:0007610 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 7.06e-04 | 63 | 57 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell differentiation | 7.40e-04 | 64 | 57 | 3 | GO:0046638 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell activation | 8.47e-04 | 153 | 57 | 4 | GO:0035710 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 8.64e-04 | 561 | 57 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation | 9.33e-04 | 157 | 57 | 4 | GO:0046632 | |
| GeneOntologyBiologicalProcess | regulation of artery morphogenesis | 9.94e-04 | 17 | 57 | 2 | GO:1905651 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.05e-03 | 580 | 57 | 7 | GO:0022407 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.08e-03 | 423 | 57 | 6 | GO:0002696 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 1.09e-03 | 73 | 57 | 3 | GO:0060119 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell differentiation | 1.09e-03 | 73 | 57 | 3 | GO:0043370 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.16e-03 | 429 | 57 | 6 | GO:1902105 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.17e-03 | 75 | 57 | 3 | GO:0050982 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 MED4 SGSM1 GLI1 ARID2 MYT1 RIPK2 KMT2A NFKBIZ NOTCH4 CRTC2 | 1.30e-03 | 1390 | 57 | 11 | GO:0045944 |
| GeneOntologyBiologicalProcess | lymphocyte activation | 1.33e-03 | 976 | 57 | 9 | GO:0046649 | |
| GeneOntologyBiologicalProcess | venous blood vessel development | 1.38e-03 | 20 | 57 | 2 | GO:0060841 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 1.43e-03 | 447 | 57 | 6 | GO:1903037 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 1.46e-03 | 614 | 57 | 7 | GO:0051249 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 1.46e-03 | 449 | 57 | 6 | GO:0050867 | |
| Domain | SAM_1 | 4.77e-05 | 68 | 55 | 4 | PF00536 | |
| Domain | Growth_fac_rcpt_ | 9.47e-05 | 156 | 55 | 5 | IPR009030 | |
| Domain | EGF-like_CS | 1.15e-04 | 261 | 55 | 6 | IPR013032 | |
| Domain | EGF_2 | 1.25e-04 | 265 | 55 | 6 | PS01186 | |
| Domain | Znf_C2HC | 1.27e-04 | 6 | 55 | 2 | IPR002515 | |
| Domain | zf-C2HC | 1.27e-04 | 6 | 55 | 2 | PF01530 | |
| Domain | SAM | 1.31e-04 | 88 | 55 | 4 | SM00454 | |
| Domain | SAM_DOMAIN | 1.76e-04 | 95 | 55 | 4 | PS50105 | |
| Domain | ZF_CCHHC | 1.77e-04 | 7 | 55 | 2 | PS51802 | |
| Domain | SAM | 1.90e-04 | 97 | 55 | 4 | IPR001660 | |
| Domain | - | 2.68e-04 | 106 | 55 | 4 | 1.10.150.50 | |
| Domain | Na_channel_asu | 3.77e-04 | 10 | 55 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.77e-04 | 10 | 55 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 3.77e-04 | 10 | 55 | 2 | PF06512 | |
| Domain | SAM/pointed | 3.90e-04 | 117 | 55 | 4 | IPR013761 | |
| Domain | - | 8.72e-04 | 15 | 55 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 8.72e-04 | 15 | 55 | 2 | SM00501 | |
| Domain | ARID_dom | 8.72e-04 | 15 | 55 | 2 | IPR001606 | |
| Domain | ARID | 8.72e-04 | 15 | 55 | 2 | PS51011 | |
| Domain | ARID | 8.72e-04 | 15 | 55 | 2 | PF01388 | |
| Domain | EGF_1 | 9.09e-04 | 255 | 55 | 5 | PS00022 | |
| Domain | AT_hook | 9.95e-04 | 16 | 55 | 2 | PF02178 | |
| Domain | EGF_CA | 2.08e-03 | 86 | 55 | 3 | PF07645 | |
| Domain | Znf_C2H2-like | 2.17e-03 | 796 | 55 | 8 | IPR015880 | |
| Domain | Znf_C2H2 | 2.33e-03 | 805 | 55 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.38e-03 | 808 | 55 | 8 | SM00355 | |
| Domain | cEGF | 2.64e-03 | 26 | 55 | 2 | IPR026823 | |
| Domain | cEGF | 2.64e-03 | 26 | 55 | 2 | PF12662 | |
| Domain | EGF_Ca-bd_CS | 2.93e-03 | 97 | 55 | 3 | IPR018097 | |
| Domain | EGF_CA | 3.10e-03 | 99 | 55 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.19e-03 | 100 | 55 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.76e-03 | 106 | 55 | 3 | IPR000152 | |
| Domain | Ion_trans_dom | 4.61e-03 | 114 | 55 | 3 | IPR005821 | |
| Domain | Ion_trans | 4.61e-03 | 114 | 55 | 3 | PF00520 | |
| Domain | EGF | 5.04e-03 | 235 | 55 | 4 | SM00181 | |
| Domain | EGF_CA | 5.57e-03 | 122 | 55 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.83e-03 | 124 | 55 | 3 | IPR001881 | |
| Domain | EGF-like_dom | 6.18e-03 | 249 | 55 | 4 | IPR000742 | |
| Domain | BROMODOMAIN_2 | 6.49e-03 | 41 | 55 | 2 | PS50014 | |
| Domain | Pkinase_Tyr | 6.50e-03 | 129 | 55 | 3 | PF07714 | |
| Domain | BROMO | 6.80e-03 | 42 | 55 | 2 | SM00297 | |
| Domain | Bromodomain | 6.80e-03 | 42 | 55 | 2 | IPR001487 | |
| Domain | - | 6.80e-03 | 42 | 55 | 2 | 1.20.920.10 | |
| Domain | ZINC_FINGER_C2H2_2 | 7.40e-03 | 775 | 55 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 7.50e-03 | 777 | 55 | 7 | PS00028 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 7.82e-03 | 138 | 55 | 3 | IPR001245 | |
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 2.64e-06 | 2 | 57 | 2 | 16111501 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11788580 | ||
| Pubmed | The cell and molecular basis of mechanical, cold, and inflammatory pain. | 7.91e-06 | 3 | 57 | 2 | 18669863 | |
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 7.91e-06 | 3 | 57 | 2 | 26716708 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 19699781 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 22449024 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 26971948 | ||
| Pubmed | Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. | 7.91e-06 | 3 | 57 | 2 | 22875917 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 28074005 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 38999942 | ||
| Pubmed | Differential roles of BAF and PBAF subunits, Arid1b and Arid2, in MLL-AF9 leukemogenesis. | 7.91e-06 | 3 | 57 | 2 | 35022500 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15314237 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 24382590 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 7.91e-06 | 3 | 57 | 2 | 30554136 | |
| Pubmed | Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. | 7.91e-06 | 3 | 57 | 2 | 32763164 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 34512623 | ||
| Pubmed | Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis. | 1.58e-05 | 4 | 57 | 2 | 38172636 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 18463357 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 10198179 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 22260870 | ||
| Pubmed | Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor. | 1.58e-05 | 4 | 57 | 2 | 34417259 | |
| Pubmed | Analgesic targets identified in mouse sensory neuron somata and terminal pain translatomes. | 1.58e-05 | 4 | 57 | 2 | 39163201 | |
| Pubmed | Nedd4-2 haploinsufficiency causes hyperactivity and increased sensitivity to inflammatory stimuli. | 1.58e-05 | 4 | 57 | 2 | 27604420 | |
| Pubmed | Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. | 1.58e-05 | 4 | 57 | 2 | 22531176 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.38e-05 | 351 | 57 | 6 | 38297188 | |
| Pubmed | Notch4 normalization reduces blood vessel size in arteriovenous malformations. | 2.63e-05 | 5 | 57 | 2 | 22261032 | |
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 2.63e-05 | 5 | 57 | 2 | 12672490 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 9421796 | ||
| Pubmed | Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. | 2.63e-05 | 5 | 57 | 2 | 37117223 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 3.56e-05 | 560 | 57 | 7 | 21653829 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 16029194 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 38816354 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 28591638 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.94e-05 | 6 | 57 | 2 | 23652591 | |
| Pubmed | 4.96e-05 | 808 | 57 | 8 | 20412781 | ||
| Pubmed | Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. | 5.51e-05 | 7 | 57 | 2 | 18952909 | |
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 5.51e-05 | 7 | 57 | 2 | 24440715 | |
| Pubmed | 5.51e-05 | 7 | 57 | 2 | 11696590 | ||
| Pubmed | 5.51e-05 | 7 | 57 | 2 | 23575686 | ||
| Pubmed | 6.25e-05 | 255 | 57 | 5 | 15324660 | ||
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 25101983 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 7.72e-05 | 861 | 57 | 8 | 36931259 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 8.19e-05 | 139 | 57 | 4 | 16985003 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 23556151 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 16382098 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 7544395 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 9.43e-05 | 9 | 57 | 2 | 8854872 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 32075728 | ||
| Pubmed | Bone marrow endosteal stem cells dictate active osteogenesis and aggressive tumorigenesis. | 9.43e-05 | 9 | 57 | 2 | 37185464 | |
| Pubmed | 1.15e-04 | 57 | 57 | 3 | 24952745 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 25055868 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 12665591 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 15922553 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.18e-04 | 10 | 57 | 2 | 23129809 | |
| Pubmed | 1.18e-04 | 469 | 57 | 6 | 27634302 | ||
| Pubmed | 1.40e-04 | 61 | 57 | 3 | 20305087 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 36030255 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 23144319 | ||
| Pubmed | 1.70e-04 | 65 | 57 | 3 | 26655900 | ||
| Pubmed | MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program. | 1.72e-04 | 12 | 57 | 2 | 27462455 | |
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 36082581 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 35904071 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 15123669 | ||
| Pubmed | Several common variants modulate heart rate, PR interval and QRS duration. | 2.37e-04 | 14 | 57 | 2 | 20062063 | |
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 28893945 | ||
| Pubmed | P53 independent pathogenic mechanisms contribute to BubR1 microcephaly. | 2.37e-04 | 14 | 57 | 2 | 37900274 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 2.51e-04 | 186 | 57 | 4 | 33637726 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 2.59e-04 | 75 | 57 | 3 | 37298722 | |
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 38413714 | ||
| Pubmed | Lymphatic mimicry in maternal endothelial cells promotes placental spiral artery remodeling. | 2.73e-04 | 15 | 57 | 2 | 31415243 | |
| Pubmed | Sonic hedgehog expressing and responding cells generate neuronal diversity in the medial amygdala. | 3.53e-04 | 17 | 57 | 2 | 20507551 | |
| Pubmed | An entosis-like process induces mitotic disruption in Pals1 microcephaly pathogenesis. | 3.53e-04 | 17 | 57 | 2 | 36604424 | |
| Pubmed | 3.53e-04 | 17 | 57 | 2 | 11078522 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.83e-04 | 208 | 57 | 4 | 33230847 | |
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 16678147 | ||
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 34446743 | ||
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 18093989 | ||
| Pubmed | Loss of endogenous thymosin β4 accelerates glomerular disease. | 3.97e-04 | 18 | 57 | 2 | 27575556 | |
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 14687547 | ||
| Pubmed | Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes. | 3.97e-04 | 18 | 57 | 2 | 16897342 | |
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 20627076 | ||
| Pubmed | Coronary arteries form by developmental reprogramming of venous cells. | 4.43e-04 | 19 | 57 | 2 | 20336138 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 4.43e-04 | 19 | 57 | 2 | 12110891 | |
| Pubmed | Sox17 is indispensable for acquisition and maintenance of arterial identity. | 4.92e-04 | 20 | 57 | 2 | 24153254 | |
| Pubmed | Programmed cell senescence during mammalian embryonic development. | 5.43e-04 | 21 | 57 | 2 | 24238962 | |
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 25369838 | ||
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 29659575 | ||
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 37045597 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 5.59e-04 | 877 | 57 | 7 | 20211142 | |
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 37532091 | ||
| Pubmed | Klf2 is an essential regulator of vascular hemodynamic forces in vivo. | 5.97e-04 | 22 | 57 | 2 | 17141159 | |
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 35293576 | ||
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 28715412 | ||
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 28432216 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 6.21e-04 | 101 | 57 | 3 | 23382219 | |
| Pubmed | 6.39e-04 | 102 | 57 | 3 | 9734811 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 6.39e-04 | 102 | 57 | 3 | 15778465 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 6.53e-04 | 23 | 57 | 2 | 30962207 | |
| Pubmed | Cerebellar cortical lamination and foliation require cyclin A2. | 6.53e-04 | 23 | 57 | 2 | 24184637 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 6.53e-04 | 23 | 57 | 2 | 8804307 | |
| GeneFamily | Sterile alpha motif domain containing | 5.59e-05 | 88 | 43 | 4 | 760 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.97e-04 | 9 | 43 | 2 | 1203 | |
| GeneFamily | AT-rich interaction domain containing | 5.69e-04 | 15 | 43 | 2 | 418 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 163 | 56 | 5 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 163 | 56 | 5 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 2.24e-06 | 168 | 56 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 2.73e-06 | 175 | 56 | 5 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 4.09e-06 | 190 | 56 | 5 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 198 | 56 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.12e-06 | 199 | 56 | 5 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.12e-06 | 199 | 56 | 5 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.25e-06 | 200 | 56 | 5 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 145 | 56 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.71e-05 | 149 | 56 | 4 | 32e0be7da42d26956683b21a1e7ae6915e4c16fb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.12e-05 | 153 | 56 | 4 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.22e-05 | 154 | 56 | 4 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 156 | 56 | 4 | c841faa1695ff577b0774f531adf1343d05dce9e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 156 | 56 | 4 | 21baf8c6e62bb7fd1530c2c100f73c0cecee092e | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.90e-05 | 160 | 56 | 4 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.90e-05 | 160 | 56 | 4 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 162 | 56 | 4 | 4c6e0cadd0ff50b0f50e0cfdc9027210e72674b9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.14e-05 | 162 | 56 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 164 | 56 | 4 | 939d4e3911fce185b986639c815de0a0389f6cfd | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 164 | 56 | 4 | 3281f2452cc6b11f3e030a3942002b9457dde6fe | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-05 | 165 | 56 | 4 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.65e-05 | 166 | 56 | 4 | 7bf7c2854cf7d85b3ae07256bbe86ae9184d6b57 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.79e-05 | 167 | 56 | 4 | 7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.79e-05 | 167 | 56 | 4 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 167 | 56 | 4 | a038c522e4783cb62802f613d00bd5f3e3797199 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | b46e446067c6425bd5b8ef7719aeecff5e861249 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 5508b03fbf483fce7701d6c82c297ffda3b1ba05 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.20e-05 | 170 | 56 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-05 | 170 | 56 | 4 | 138235227fc4c3d660c3a06e8e5167bf64f076b3 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 6.49e-05 | 172 | 56 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 6.49e-05 | 172 | 56 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.63e-05 | 173 | 56 | 4 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 174 | 56 | 4 | 9019011eb8d9b7a95804fc11434f0fd42418103a | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 174 | 56 | 4 | deafbd0c2523afe09cc42f8c7b33945f3f5c00b4 | |
| ToppCell | droplet-Tongue-Unstain-18m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 174 | 56 | 4 | f2eb0199f59e1e2f46da344c05289876bd254fa3 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 177 | 56 | 4 | b6c0ab701d9db3f19605b4d23f7e40adca3324e1 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 177 | 56 | 4 | 34bd46704827c9db7053bbd0c671dd0b661b79b4 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 177 | 56 | 4 | 8f4b2f21091d981c12000489054198127098f62c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.57e-05 | 179 | 56 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 180 | 56 | 4 | 8cef63866c205df3825df84ce51fa61aa04ae491 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | cf32603ad9b9882b0bb873327d58b50dd26a5bd3 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 182 | 56 | 4 | 71cfd0b6d464e3e1b1cca34f423abdf699cda48a | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.25e-05 | 183 | 56 | 4 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.42e-05 | 184 | 56 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-05 | 184 | 56 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.42e-05 | 184 | 56 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.42e-05 | 184 | 56 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.60e-05 | 185 | 56 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | 969248b63d4ce335f223528de756bcddffadbd77 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 186 | 56 | 4 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.78e-05 | 186 | 56 | 4 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 186 | 56 | 4 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.78e-05 | 186 | 56 | 4 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.78e-05 | 186 | 56 | 4 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.78e-05 | 186 | 56 | 4 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-05 | 186 | 56 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.78e-05 | 186 | 56 | 4 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.78e-05 | 186 | 56 | 4 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.78e-05 | 186 | 56 | 4 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 8.78e-05 | 186 | 56 | 4 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.78e-05 | 186 | 56 | 4 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.78e-05 | 186 | 56 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 187 | 56 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 187 | 56 | 4 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 8.96e-05 | 187 | 56 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.96e-05 | 187 | 56 | 4 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-05 | 188 | 56 | 4 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.15e-05 | 188 | 56 | 4 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.15e-05 | 188 | 56 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-05 | 188 | 56 | 4 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | COVID-19_Severe-pDC|World / disease group, cell group and cell class | 9.15e-05 | 188 | 56 | 4 | 4c8e328b8206120708b05ea3c5865a0200dc5c4e | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.15e-05 | 188 | 56 | 4 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.34e-05 | 189 | 56 | 4 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 189 | 56 | 4 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 189 | 56 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.34e-05 | 189 | 56 | 4 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 9.34e-05 | 189 | 56 | 4 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 189 | 56 | 4 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 9.34e-05 | 189 | 56 | 4 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.34e-05 | 189 | 56 | 4 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 190 | 56 | 4 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 190 | 56 | 4 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 9.53e-05 | 190 | 56 | 4 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.53e-05 | 190 | 56 | 4 | 9b8de47f7a2e6137d934ccce32417ab15eb54f46 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 9.53e-05 | 190 | 56 | 4 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-gdT|Bac-SEP / Disease, Lineage and Cell Type | 9.53e-05 | 190 | 56 | 4 | c7c5bc50082b2243cae8eb04784d03f14a739b3b | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 9.73e-05 | 191 | 56 | 4 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.73e-05 | 191 | 56 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 9.73e-05 | 191 | 56 | 4 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.73e-05 | 191 | 56 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.92e-05 | 192 | 56 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.92e-05 | 192 | 56 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 1.01e-04 | 193 | 56 | 4 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-04 | 193 | 56 | 4 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 1.01e-04 | 193 | 56 | 4 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 194 | 56 | 4 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 195 | 56 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 195 | 56 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 9.85e-06 | 3 | 54 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 9.85e-06 | 3 | 54 | 2 | C0014805 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 6.86e-05 | 7 | 54 | 2 | C0020075 | |
| Disease | Congenital Pain Insensitivity | 6.86e-05 | 7 | 54 | 2 | C0002768 | |
| Disease | hemangiopericytoma (is_marker_for) | 1.17e-04 | 9 | 54 | 2 | DOID:264 (is_marker_for) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.14e-04 | 12 | 54 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 2.53e-04 | 13 | 54 | 2 | C0265338 | |
| Disease | T wave morphology measurement | 2.95e-04 | 14 | 54 | 2 | EFO_0008398 | |
| Disease | Neuralgia, Supraorbital | 3.88e-04 | 16 | 54 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 3.88e-04 | 16 | 54 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 3.88e-04 | 16 | 54 | 2 | C0423711 | |
| Disease | Neuralgia | 3.88e-04 | 16 | 54 | 2 | C0027796 | |
| Disease | Romano-Ward Syndrome | 3.88e-04 | 16 | 54 | 2 | C0035828 | |
| Disease | Neuralgia, Atypical | 3.88e-04 | 16 | 54 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 3.88e-04 | 16 | 54 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 3.88e-04 | 16 | 54 | 2 | C0751373 | |
| Disease | Nerve Pain | 3.88e-04 | 16 | 54 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 3.88e-04 | 16 | 54 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 3.88e-04 | 16 | 54 | 2 | C0042656 | |
| Disease | QT interval | 4.23e-04 | 534 | 54 | 6 | EFO_0004682 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 5.51e-04 | 19 | 54 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 5.51e-04 | 19 | 54 | 2 | C2936783 | |
| Disease | Neurodevelopmental Disorders | 6.69e-04 | 93 | 54 | 3 | C1535926 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.04e-03 | 26 | 54 | 2 | C0009405 | |
| Disease | Epilepsy | 1.06e-03 | 109 | 54 | 3 | C0014544 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.12e-03 | 27 | 54 | 2 | C1112155 | |
| Disease | cytotoxicity measurement, response to clozapine | 1.29e-03 | 29 | 54 | 2 | EFO_0006952, GO_0097338 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.29e-03 | 29 | 54 | 2 | C1333990 | |
| Disease | cancer (implicated_via_orthology) | 1.47e-03 | 268 | 54 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 1.67e-03 | 33 | 54 | 2 | EFO_0007905 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCENPGVPRHGSQNN | 3351 | Q7Z407 | |
| ATFGHGANTGAQCPP | 16 | Q07092 | |
| GGPPQSSVVQNHSTG | 736 | Q68CP9 | |
| AGPCFDQHGGQQSPG | 331 | Q8NFD5 | |
| CTAGQSHPDGSPQQG | 521 | Q92625 | |
| ASEPQTRHGSQGPGQ | 226 | Q9BXF3 | |
| HSGQGALNCESAPQG | 806 | Q8TEW8 | |
| AHITQPCGSGGSVDP | 636 | P51787 | |
| PQSSPAEQCQDFHGG | 246 | Q9BYH8 | |
| GEGSCQPCPANSHSN | 281 | P54760 | |
| PGGLTVNNCQPAGHV | 36 | Q6A163 | |
| ACGPHQAAGPDLGSS | 171 | Q9Y468 | |
| ALSGPHPQSGGQDND | 406 | Q6ZU69 | |
| ALSGPHPQSGGQDND | 136 | Q63HN1 | |
| HIDSNGNSSPGCSPQ | 651 | O15409 | |
| NPQGSLSSECNPHGG | 786 | P55268 | |
| GTEGLSGPPFCHQAN | 31 | P08151 | |
| PEAHSQEQGHPQTGC | 71 | Q6NT46 | |
| NNPSTNGVNGHLPGD | 191 | Q9NPJ6 | |
| DPGSSQSPGQCGDNT | 481 | Q68CR7 | |
| PSVQHGGRPCEGNAV | 4616 | Q96RW7 | |
| TQPQAPHCSDGQGHL | 481 | P26010 | |
| SPPSGQEGQQGAECG | 416 | Q9UBL9 | |
| ATPGGCPNDNSIEHS | 111 | Q9BYU1 | |
| SVQSSGGQPPGRQSH | 516 | Q53ET0 | |
| PASSSHGGGLDQPCQ | 21 | H7C350 | |
| GSGSHCSPDGAPQVL | 371 | O75128 | |
| LQNPPAIHGSGSGSC | 341 | Q9H410 | |
| ALGEGPGASPCNQHS | 341 | P31785 | |
| SPPCGSVEQGHGNNQ | 3006 | Q03164 | |
| CQGSSCQPVSGEGQP | 186 | A8MX34 | |
| PTDSQGHFCGQKGTP | 71 | Q8NCS7 | |
| PAQSDPGQCPDQSHG | 416 | Q6PII3 | |
| GTDSFNGHPPQGCAS | 541 | Q9NVU0 | |
| VAGGSNPGAHNPSAN | 1181 | O14654 | |
| PLEQGSSCNGPGQTT | 356 | Q9Y2M0 | |
| PTNCHPGLGTENQSH | 96 | Q8NET5 | |
| PEAHSQEQGHPQTGC | 71 | Q13066 | |
| HPGSSVEGDCGNPSV | 1721 | Q15858 | |
| QGPPHCRNGGTCQNS | 321 | Q99466 | |
| TACAGTQPGAQPGAQ | 611 | Q17R89 | |
| SQSCQEGGGHDLLPP | 36 | Q9H0A9 | |
| QPGPQAQCSSGGRTH | 1286 | Q9H2D6 | |
| TTCGASGPHGPTQAQ | 686 | Q9UM73 | |
| HPNPEGSQKDGNFSC | 301 | Q14246 | |
| NSPAHQALCSGNPGQ | 401 | Q15596 | |
| PDGASCQGQPALHSE | 676 | Q9H9J4 | |
| GDSGCHNPLSESPQG | 326 | A0A0J9YY54 | |
| ADSGQPGTQEACGQP | 121 | Q9UPR6 | |
| PGTQEACGQPSPHGS | 126 | Q9UPR6 | |
| HLGGNPDQCSEPGGN | 816 | P17040 | |
| NLPNSNGTRGDCGSP | 1681 | Q9Y5Y9 | |
| PVNHGPQEESCGSSQ | 336 | O43353 | |
| THRGNPGCSGSQTAQ | 946 | Q6ZS81 | |
| GNLVNGTCSPDSGHP | 756 | Q2NKQ1 | |
| TGSPGKQPGENSDCH | 221 | P17098 | |
| VSHCGPNANPSDGNN | 501 | Q2M1K9 | |
| HGAAFPPGSSCGQQQ | 136 | Q8IVC4 | |
| PPGSSCGQQQEVHVA | 141 | Q8IVC4 | |
| GASGGLQPHQLSSCD | 466 | Q9UPU9 | |
| CPTPGCTGQGHVNSN | 486 | Q01538 |